Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;20(4):715-716.
doi: 10.1016/j.jcf.2021.03.028. Epub 2021 Apr 15.

COVID-19 vaccine prioritisation for people with cystic fibrosis

Siobhán B Carr  1 , Rebecca Cosgriff  2 , Satenik Harutyunyan  1 , Peter G Middleton  1 , Rasa Ruseckaite  1 , Susannah Ahern  1 , Géraldine Daneau  1 , Luiz Vicente R F da Silva Filho  1 , Anne L Stephenson  1 , Stephanie Y Cheng  1 , Joel Melo  1 , Harriet Corvol  1 , Pierre-Régis Burgel  1 , Lutz Nährlich  1 , Edward McKone  1 , Carla Colombo  1 , Marco Salvatore  1 , Rita Padoan  1 , Olzhas Abdrakhmanov  1 , Vincent Gulmans  1 , Catherine A Byrnes  1 , Elena Amelina  1 , Elena Kondratyeva  1 , Elena Zhekayte  1 , Nataliya Kashirskaya  1 , Marco Zampoli  1 , M Dolores Pastor-Vivero  1 , Pedro Mondejar-Lopez  1 , Isabelle de Monestrol  1 , Andeas Jung  1 , Elliot McClenaghan  1 , Keith Brownlee  1 , Samar Rizvi  1 , Christopher H Goss  1 , Alexander Elbert  1 , Albert Faro  1 , Hector Gutierrez  1 , Bruce C Marshall  1
Affiliations

COVID-19 vaccine prioritisation for people with cystic fibrosis

Siobhán B Carr et al. J Cyst Fibros. 2021 Jul.
No abstract available

Keywords: COVID; Coronavirus; Cystic fibrosis; Vaccine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no conflicts of interest to declare relating to this work.

References

    1. Cosgriff R. “A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.”. J Cyst Fibros. 2020;19(3):355–358. doi: 10.1016/j.jcf.2020.04.012. - DOI - PMC - PubMed
    1. McCleneghan “The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.”. J Cyst Fibros. 2020 in press. - PMC - PubMed
    1. Bain “Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study.”. J Cyst Fibros. 2020 in press. - PMC - PubMed
    1. BMJ. 2020;371:m4750. - PubMed

Substances